Logistics and Infrastructure: UK Radiopharmaceuticals Market Growth The primary engine of expansion in the British nuclear medicine sector is the renewal of aging infrastructure. This modernization is a core catalyst for UK Radiopharmaceuticals Market growth, as the government invests in new radiochemistry labs and cyclotron facilities. These facilities are the backbone of the market, allowing for the domestic production of essential isotopes like Fluorine-18...